文献速递神经肿瘤

儿童低级别胶质瘤:生物学驱动的下一步

Pediatric low-grade gliomas: next biologically driven steps.
PubMed 文献 · Neuro Oncol · 2018-01-01

本文总结2016年意大利帕多瓦第二届儿童低级别胶质瘤国际共识会议的讨论与建议,涵盖基因组学、模型系统、成人与儿童弥漫性胶质瘤的分子与组织病理差异、靶向治疗推向晚期临床试验的步骤及Ras/丝裂原活化蛋白激酶通路改变的诊断评估。

要点

  • 儿童低级别胶质瘤虽通常不致命,但因共病和易复发而成为慢性临床难题。
  • 会议讨论了基因组学、模型系统及成人与儿童弥漫性胶质瘤的分子与组织病理差异。
  • 会议提出需加快靶向治疗进入新诊断病例的晚期临床试验,并评估Ras/MAPK通路改变的诊断方法。

核心结论

  • 会议总体基调积极,共识认为研究进展正在并将继续取得,同时承认这一复杂肿瘤群体带来的挑战规模。
  • 会议小组的结论与建议作为当前思考的纲要和进一步讨论的基础。

研究设计与样本

  • 2016年在意大利帕多瓦召开的第二届儿童低级别胶质瘤国际共识会议。

主要发现

  • 儿童低级别胶质瘤是儿童期最常见的脑肿瘤,常成为需要数十年管理的慢性问题。
  • 会议讨论了日益增长的肿瘤基因组学理解、可用模型系统的评估、成人与儿童弥漫性胶质瘤的分子与组织病理差异。
  • 会议讨论了加快靶向治疗进入新诊断病例晚期临床试验所需的步骤,并考虑了Ras/丝裂原活化蛋白激酶通路改变(这些肿瘤的典型特征)的诊断评估方法。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the fact that they are not typically life-threatening, low-grade gliomas (LGGs) remain a significant clinical challenge in pediatric neuro-oncology due to comorbidities associated with these tumors and/or their treatments, and their propensity to multiply recurs. LGGs, in total the most common brain tumors arising in childhood, can often become a chronic problem requiring decades of management. The Second International Consensus Conference on Pediatric Low-Grade Gliomas held in Padua, Italy in 2016 was convened in an attempt to advance the pace of translating biological discoveries on LGGs into meaningful clinical benefit. Topics discussed included: the implications of our growing biological understanding of the genomics underlying these tumors; the assessment of the model systems available; the implications of the molecular and histopathologic differences between adult and pediatric diffuse gliomas; and steps needed to expedite targeted therapy into late-stage clinical trials for newly diagnosed cases. Methods for the diagnostic assessment of alterations in the Ras/mitogen-activated protein kinase pathway, typical for these tumors, were also considered. While the overall tone was positive, with a consensus that progress is being and will continue to be made, the scale of the challenge presented by this complex group of tumors was also acknowledged. The conclusions and recommendations of the meeting panel are provided here as an outline of current thinking and a basis for further discussion.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Jones DTW, Kieran MW, Bouffet E, et al. Pediatric low-grade gliomas: next biologically driven steps. Neuro Oncol. 2018. PMID: 29016845. doi:10.1093/neuonc/nox141

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。